Page last updated: 2024-10-30

metformin and Clostridioides difficile Infection

metformin has been researched along with Clostridioides difficile Infection in 3 studies

Metformin: A biguanide hypoglycemic agent used in the treatment of non-insulin-dependent diabetes mellitus not responding to dietary modification. Metformin improves glycemic control by improving insulin sensitivity and decreasing intestinal absorption of glucose. (From Martindale, The Extra Pharmacopoeia, 30th ed, p289)
metformin : A member of the class of guanidines that is biguanide the carrying two methyl substituents at position 1.

Research Excerpts

ExcerptRelevanceReference
"Here metformin hydrochloride was suggested to be useful for the treatment of recurrent CDI with type 2 diabetes mellitus."1.91[A case of recurrent Clostridium difficile infection with type 2 diabetes mellitus indicating the usefulness of metformin hydrochloride]. ( Obata, K; Yamashita, S, 2023)
"Data on risk factors for Clostridium difficile infection (CDI) in diabetic patients are scarce."1.42Predicting Clostridium difficile infection in diabetic patients and the effect of metformin therapy: a retrospective, case-control study. ( Barsheshet, A; Bishara, J; Eliakim-Raz, N; Fishman, G; Goldberg, E; Stein, GY; Yahav, D; Zvi, HB, 2015)

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (66.67)24.3611
2020's1 (33.33)2.80

Authors

AuthorsStudies
Obata, K1
Yamashita, S1
Staley, C1
Kaiser, T1
Vaughn, BP1
Graiziger, C1
Hamilton, MJ1
Kabage, AJ1
Khoruts, A1
Sadowsky, MJ1
Eliakim-Raz, N1
Fishman, G1
Yahav, D1
Goldberg, E1
Stein, GY1
Zvi, HB1
Barsheshet, A1
Bishara, J1

Clinical Trials (1)

Trial Overview

TrialPhaseEnrollmentStudy TypeStart DateStatus
Aiming to Reduce Disease-related Gastrointestinal Symptoms in Systemic Sclerosis by Repeat Intestinal Infusions of Anaerobic Cultivated Human Intestinal Microbiome (ACHIM); a Randomized, Double-blind Placebo-controlled 20 Week Study[NCT04300426]Phase 275 participants (Actual)Interventional2020-09-24Completed
[information is prepared from clinicaltrials.gov, extracted Sep-2024]

Other Studies

3 other studies available for metformin and Clostridioides difficile Infection

ArticleYear
[A case of recurrent Clostridium difficile infection with type 2 diabetes mellitus indicating the usefulness of metformin hydrochloride].
    Nihon Shokakibyo Gakkai zasshi = The Japanese journal of gastro-enterology, 2023, Volume: 120, Issue:2

    Topics: Aged; Anti-Bacterial Agents; Clostridioides difficile; Clostridium Infections; Diabetes Mellitus, Ty

2023
Durable Long-Term Bacterial Engraftment following Encapsulated Fecal Microbiota Transplantation To Treat Clostridium difficile Infection.
    mBio, 2019, 07-23, Volume: 10, Issue:4

    Topics: Adult; Aged; Bacteroidetes; Bayes Theorem; Clostridioides difficile; Clostridium Infections; Cohort

2019
Predicting Clostridium difficile infection in diabetic patients and the effect of metformin therapy: a retrospective, case-control study.
    European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology, 2015, Volume: 34, Issue:6

    Topics: Adult; Aged; Aged, 80 and over; Case-Control Studies; Clostridioides difficile; Clostridium Infectio

2015